Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/880| Title: | Obstetric implications of current Australian product information for thyroid-related medications. |
| Epworth Authors: | Stockigt, Jim R. |
| Keywords: | Antithyroid Agents Administration & Dosage Breast Feeding Dose-Response Relationship, Drug Drug Administration Schedule Hormone Replacement Therapy Hyperthyroidism Drug Therapy Hypothyroidism Complications Pregnancy Pregnancy Complications Product Labeling Thyroxine Australia Department of Endocrinology and Diabetes, Epworth HealthCare, Victoria, Australia UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia Obstetrics and Gynaecology Clinical Institute, Epworth HealthCare, Victoria, Australia |
| Issue Date: | Feb-2009 |
| Publisher: | Wiley |
| Citation: | Aust N Z J Obstet Gynaecol. 2009 Feb;49(1):64-6. |
| URI: | http://hdl.handle.net/11434/880 |
| DOI: | 10.1111/j.1479-828X.2008.00944.x |
| PubMed URL: | https://www.ncbi.nlm.nih.gov/pubmed/19281582 |
| ISSN: | 1479-828X |
| Journal Title: | Australian and New Zealand Journal of Obstetrics and Gynaecology |
| Type: | Journal Article |
| Affiliated Organisations: | Monash University, Victoria, Australia Alfred Hospital, Melbourne, Victoria, Australia |
| Appears in Collections: | UroRenal, Vascular Women's and Children's |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.